Trial
NCT02857218
Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
OHSU Knight Cancer Institute
Collaborators
Oregon Health and Science University
Condition
Stage IIB Esophageal Cancer AJCC v7
Intervention
Ferumoxytol
Why stopped
Inadequate enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-16